Outcomes of Imetelstat Therapy In Patients with Ring Sideroblast-Negative Lower-Risk Myelodysplastic Syndromes From The Pooled Imerge Study Populations

Geron Corporation published this content on June 14, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 14, 2025 at 18:27 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io